A VENOUS SINUS THROMBOSIS CASE IN THE PUERPERIUM PERIOD

Year 2020, Volume: 2 Issue: 3, 111 - 113, 26.10.2020

Özge Yücel Erol Nadi Varlı , Ayberk Çakır , Afife Nur Taner , Özgür Şahin , Harun Egemen Tolunay

https://doi.org/10.37990/medr.796629

Abstract

Venous sinus thrombosis is a condition that can present different symptoms, from a deep coma to isolated headaches. However, 60% of the cases were found to be seen in these periods due to increased coagulation factors during pregnancy and puerperium. In our case, our patient who gave birth with C / S abdominal due to twin pregnancy in labor, venous sinus thrombosis was detected in intracranial imaging performed after a tonic-clonic seizure on the 12th day of postpartum. If not diagnosed, morbidity and mortality were high, and the patient was treated in intensive care for five days and in the ward for five days after diagnosis. We wanted to raise awareness about the situation with high morbidity and mortality, which can be clinically presented even with headache, by sharing our venous sinus thrombosis case, which is likely to be seen during pregnancy and puerperium period with you.

Keywords

VENOUS SINUS THROMBOSIS, ANTICOAGULATION, PUERPERİUM

Supporting Institution

none

Project Number

none

Puerperium Döneminde Gerçekleşen Venöz Sinüs Trombozu Olgusu

Abstract

Venöz sinus trombozu nadir görülen derin komadan izole baş ağrılarına kadar farklı şekilde semptom verebilen bir durumdur.
Fakat %60 vakanın gebe ve lohusalık döneminde artan pıhtılaşma faktörlerine bağlı olarak bu dönemlerde görüldüğü saptanmıştır.
Olgumuzda eylemde ikiz gebelik nedeniyle C/S abdominale ile doğum yapan hastamızın postpartum 12.gününde geçirdiği tonik klonik
nöbeti sonrası yapılan intrakranial görüntülemede venöz sinus trombozu tespit edilmiştir.Erken tanı konulmadığı takdirde morbidite
ve mortalitenin yüksek olduğu bu durumda hastanın tanı sonrası 5gün yoğun bakım 5 gün serviste tedavisi gerçekleştirilmiştir. Biz
gebelikte ve puerperium döneminde görülme ihtimali artan venöz sinus trombozu olgumuzu sizle paylaşarak sadece izole baş ağrısı
ile bile klinik olarak prezente olabilen morbidite ve mortalitesi yüksek olan durum hakkında farkındalığı arttırmak istedik.

Keywords

Venöz sinüs trombozu, antikoagülasyon, lohusalık

Project Number

none

References

• 1- Einhupl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. European Journal of Neurology 2010;17:1229–35.
• 2- Cantú C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: a review of 67 cases. Stroke 1993;24:1880–4.
• 3-TreadwellSD,ThanviB,RobinsonTG.Strokeinpregnancyandthepuerperium. Postgraduate Medical Journal 2008;84:238–45.
• 4-Sharpe CJ, Crowther MA, Webert KE, Donnery C. Cerebral venous thrombosis during pregnancy in the setting of type I antithrombin deficiency: case report and literature review. Transfusion Medicine Reviews 2011;25:61–5.
• 5-Repetto MF, De All J, Romero G, Herrando S, Gómez E, Gnocchi C. Postpartum cerebral venous sinus thrombosis. Medicina 2011;71:380.
• 6-Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol- ogy 2007;6:162–70.
• 7-Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis. Results of International study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 2004; 35: 664-70.
• 8- Kamisli O, Kamisli S, Kablan Y, Gonullu S, Ozcan C. The prognostic 
value of an increased mean platelet volume and platelet distribution width in the early phase of cerebral venous sinus thrombosis. Clin Appl Thromb Hemost 2013; 19: 29-32. 

• 9-Horowitz M, Purdy P, Unwin H, Carstens G 3rd, Greenlee R, Hise J,et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995; 38: 58-67.
• 10-Kim SY, Suh JH. Direct endovascular thrombolytic therapy for dural sinus thrombosis: Infusion of altepase. AJNR Am J Neuroradiol 1997; 18: 639-45.
• 11- de Brujin SFTM, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low molecular weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-8.